Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Niacin and Niacinamide Market Outlook (2022 to 2032)

[184 Pages Report] The global niacin and niacinamide market was valued at US$ 1.2 Billion in 2021 and is expected to reach US$ 2.5 Billion by 2032. Demand in the market is poised to rise at a robust 5.2% CAGR over the forecast period (2022 to 2032). Growth in the market is underpinned by rising awareness regarding skincare and the increasing use of liquid niacinamide in the cosmetic and personal care industry.

With the growing penetration of social media and the advent of influencer marketing, the demand in the market is predicted to burgeon at a rapid pace over the upcoming decade. Niacinamide is the most essential ingredient in the skincare regime. Liquid niacinamide aids in brightening the skin, reducing acne or flaws on the skin, and also hydrates. Hence, numerous dermatologists and aestheticians prefer niacinamide as the most essential ingredient in beauty treatments.

Niacinamide also referred to as nicotinamide, is a type of vitamin B3. A lack of B3 can cause problems with the skin, kidneys, and brain. Utilizing niacinamide can help prevent B3 deficiency. Additionally, topical niacinamide may help treat skin conditions such as acne and eczema.

Attributes Key Insights
Niacin and Niacinamide Market Value 2021 US$ 1.02 Billion
Estimated Market Size 2022 US$ 1.23 Billion
Projected Market Value 2032 US$ 2.05 Billion
CAGR 2022 to 2032 5.2%
Share of Top 5 Countries 53.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Niacin and Niacinamide Market Outlook (2015 to 2021) Compared to Sales Forecast (2022 to 2032)

As per Future Market Insights (FMI), the overall sales in the niacin and niacinamide market grew at a CAGR of 5.3% between 2015 and 2021. The global niacin and niacinamide market held a share of approximately 1.0% of the overall US$ 123.1 Billion global dietary supplements market, in 2021.

Niacin has been widely used to lower lipoprotein, triglycerides, very-low-density lipoprotein (VLDL), total cholesterol, low-density lipoprotein (LDL) cholesterol, and statin drugs. Niacin is also the most effective agent for raising plasma levels of high-density lipoprotein (HDL) cholesterol. Niacin has shown in clinical trials that it can balance cardiovascular risk in people with diabetes mellitus or mixed dyslipidemia, reducing cardiovascular morbidity and death, particularly when taken with statin medications.

Throughout the forecast period, it is anticipated that the niacin and niacinamide market will grow more quickly than average due to rising consumer demand for the product due to its health benefits. These benefits include maintaining vitamin B3 and cholesterol levels, increasing the usage of skin care cosmetics, raising awareness of the consumption of healthy food supplements, and enhancing energy metabolism. Backed by this, FMI predicts the global niacin and niacinamide market to grow at a CAGR of 5.2% over the forecast period (2022 to 2032).

Niacin and Niacinamide Market

What are the Key Opportunities in the Niacin and Niacinamide Market?

Increasing Use of Niacin & Niacinamide in Health Supplements to Drive the Sales

Niacin (vitamin B-03) is a substance frequently used as an antioxidant in the food and beverage industry. Niacinamide also reduces the amount of harmful free radicals, which can damage DNA and cells and raise the risk of chronic illnesses like cancer and heart disease. Hence, demand for this ingredient is expected to surge in corporate as the need for superior products to maintain a pipeline of novel products in the form of supplements or the food & beverage industry.

As a result, businesses now have the opportunity to increase their market presence. Niacin exists in two chemical forms. One type is used for pellagra or nutritional supplements, while the other is utilized for hyperlipoproteinemia or peripheral vascular disease as nicotinic acid alone (niacinamide). To reduce the global burden of skin diseases, the adoption of products with niacin and niacinamide is expected to rise over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which are the Factors Restraining the Demand in the Niacin and Niacinamide Market?

Producing a new molecular entity is money-consuming and could be expensive to finish. As a result, it is projected that the market for niacin and niacinamide would be constrained by the high cost of medication research and the stringent process for regulatory clearance.

Negative side effects could result from using niacinamide at excessive dosages or without consideration for cases of moderate illnesses. As a result, it is anticipated that the rise in adverse effects brought on by inaccurate information and other unfavorable side effects would limit the growth of niacinamide demand. Nausea, vomiting, rashes, skin blistering and irritation, and allergic responses are a few minor niacinamide adverse effects.

The effectiveness of niacin in reducing the risk of heart attacks and strokes is lower in older patients with cardiovascular problems who are advised to take laropiprant and extended-release niacin.

Patients with severe hypotension, peptic ulcer disease, or liver illness should avoid excessive doses of niacin. Additionally, the supplement has been related to liver damage, can lead to hypotension, and may even result in peptic ulcers.

Country-wise Insights

How Big is the Opportunity in the USA Niacin and Niacinamide Market?

Rising Prevalence of Downer Cow Syndrome in the USA to Aid the Growth

The USA is considered to be the largest market for niacin and niacinamide and accounted for a market share of around 21.1% within the global niacin and niacinamide market in 2021. Growth in the market is poised to expand to the rising prevalence of downer cow syndrome (DCS) in dairy animals and an increase in pediatric obesity cases in the USA

Additionally, with the growing presence of numerous pharmaceutical and cosmeceutical businesses, the demand in the USA niacin and niacinamide market is predicted to grow over the forecast period.

What Makes India a Lucrative Niacin and Niacinamide Market?

Use of Niacin and Niacinamide in Beauty Products to Boost the Sales

India is an emerging market for niacin and niacinamide and accounted for a market share of 15.3% in the global niacin and niacinamide market in 2021. Due to the rapid development of chemical studies and the rising costs of healthcare in India, it is anticipated that the niacin and niacinamide market will witness lucrative growth opportunities.

With the growing expansion of the healthcare sector, India is expected to be a prominent research and development (R&D) hub for pharmaceutical manufacturers. As a result, India has improved its standing as a key influence in the international pharmaceutical sector, serving as a base for raising Research and Development while simultaneously serving as a consumer country.

Further, growing concerns regarding skincare, the adoption of niacinamide in serums is expected to boost the growth in the market. On the back of these factors, the demand in India's niacin and niacinamide market is predicted to surge at a rapid pace over the forecast period.

Will China Retain its Dominance in the Global Niacin and Niacinamide Market?

Increasing Use of Niacin and Niacinamide in the Pharmaceutical Sector to Push Sales

China led the East Asia niacin and niacinamide market with a share of around 7.5% in 2021. Small and major biopharmaceutical businesses are relying on the contract research organization (CRO) industry to supply research services to their Research and Development operations in recent years.

Due to the existence of multiple government-funded pharmaceutical and medical institutions with state-of-the-art equipment, clinical trial, and research are now significant industries in China. These factors are expected to make China one of the emerging niacin and niacinamide market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

Which Form is Most Preferred in Niacin and Niacinamide Market?

Dry Form to Contribute Nearly 4/5th of Sales in the Niacin and Niacinamide Market

On the basis of form, the dry form of niacin and niacinamide accounted for the highest share of around 76.4% in 2021. Due to its longer shelf life and lower price than the liquid form, the dry form has the largest market share. Additionally, dry niacin and niacinamide have a quicker origin of an effect than other forms, which is what is fueling the segment's market expansion.

The acceptance of niacin and niacinamide as a preferred therapy for skin rejuvenation and the rising demand for niacin and niacinamide in improving vitamin deficiency are factors expected to raise the demand for niacin and niacinamide globally.

Based on distribution channels, the pharmacies & drug stores segment dominated the market for niacin and niacinamide with a share of around 64.5% in 2021. It is the most widely adopted channel for self-prescribed drugs for daily use in skin rejuvenation and other products.

Competitive Landscape

Key players are concentrating on introducing a number of disruptive solutions and obtaining regulatory body approval in order to increase their product offerings. They are also concentrating on establishing new labs, concentrating on mergers and acquisitions, and infrastructure development.

For instance:

  • In May 2022, Lonza, and ALSA Ventures, announced a framework collaboration agreement to support the development and manufacturing of biologics and small-molecule drug candidates for ALSA's portfolio of pre-clinical and early-clinical biotechs.
  • In Dec 2021, leading science and technology company Merck announced a strategic acquisition of chord therapeutics.

Scope of the Report

Attribute Details
Estimated Market Size 2022 US$ 1.23 Billion
Projected Market Value 2032 US$ 2.05 Billion
CAGR 2022 to 2032 5.2%
Forecast Period 2022 to 2032
Historical Data Available for 2015 to 2021
Market Analysis USD Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, the UK, France, Italy, Spain, Russia, BENELUX, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Turkey, South Africa, North Africa, and GCC Countries.
Key Segments Covered Form, Distribution Channel, and Region
Key Companies Profiled
  • Lonza Group AG
  • Koninklijke DSM N.V.,
  • Bactolac Pharmaceutical Inc.,
  • Merck KGaA,
  • BASF SE,
  • Foodchem International Corporation,
  • Evonik Industries AG,
  • Jubilant Life Sciences Limited,
  • Vertellus Specialties Inc,
  • Fagron NV,
  • Others
Report Coverage Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Niacin and Niacinamide Market by Category

By Form:

  • Dry
  • Liquid

By Distribution Channel:

  • Pharmacies & Drug Stores
  • Hyper Markets and Super Market
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

How much is the niacin and niacinamide market currently worth?

The global niacin and niacinamide market is worth US$ 1.2 Billion in 2021.

What is the sales forecast for the niacin and niacinamide market through 2032?

The niacin and niacinamide market is expected to reach US$ 2.5 Billion by the end of 2032, with sales revenue expected register a 5.2% CAGR.

Which is the most lucrative region for the niacin and niacinamide market?

North America holds 27.0% of the global niacin and niacinamide market in 2021.

What is the USA outlook within the niacin and niacinamide market?

The USA led the North America niacin and niacinamide market with a share of around 21.1% in 2021.

What is the demand outlook for Japan niacin and niacinamide market?

Japan Niacin and niacinamide market is expected to account for a demand share of 5.4% in 2021.

What are the top 5 countries driving demand for niacin and niacinamide market?

USA, India, China, Japan and Germany are the top 5 countries that are driving the demand for niacin and niacinamide market.

What was the last 6 year’s CAGR value for the niacin and niacinamide market?

From 2015 to 2021, the market for niacin and niacinamide expanded at the rate of 5.3%.

What is the outlook of Germany in the global niacin and niacinamide market?

Germany held a global share of around 4.2% in 2021 in the niacin and niacinamide industry space.

Table of Content

1. Executive Summary | Niacin and Niacinamide Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Recent Product Launches

    4.3. Regulatory Scenario

    4.4. Product Adoption Analysis

    4.5. Patient Treatment Journey

    4.6. PESTLE Analysis

    4.7. Porter’s Analysis

    4.8. Key Promotional Strategies - by Key Manufacturers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Spending Outlook

        5.1.3. Global Dietary Supplements Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Cases of Skin Allergies

        5.2.2. Growing Advancements in Fields of Health and Nutrition

        5.2.3. High Global Prevalence of Acne

        5.2.4. Impact of Regulatory Control on Supplement Usage Limit

        5.2.5. Product Availability and Outreach

        5.2.6. Growing Disposable Income

        5.2.7. Product Adoption

        5.2.8. Increase in Research and Development spending

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. Revenue By Form

        6.1.2. Revenue By Distribution Channel

        6.1.3. Revenue By Country

    6.2. 2021 Market Scenario

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2021 and Forecast, 2022 to 2032

    7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021

    7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by Form

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million), By Form, 2015 to 2021

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Form, 2022 to 2032

        8.3.1. Dry

        8.3.2. Liquid

    8.4. Market Attractiveness Analysis By Form

9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million), By Distribution Channel, 2015 to 2021

    9.3. Current and Future Market Size (US$ Million) and Forecast By Distribution Channel, 2022 to 2032

        9.3.1. Pharmacies & Drug Stores

        9.3.2. Hyper Markets and Super Market

        9.3.3. Others

    9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021

    10.3. Current and Future Market Size (US$ Million) and Forecast By Region, 2022 to 2032

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia

        10.3.6. Oceania

        10.3.7. Middle East and Africa (MEA)

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        11.3.1. By Country

            11.3.1.1. United States of America

            11.3.1.2. Canada

        11.3.2. By Form

        11.3.3. By Distribution Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Form

        11.4.3. By Distribution Channel

    11.5. Market Trends

    11.6. Key Market Participants - Intensity Mapping

    11.7. Drivers and Restraints - Impact Analysis

    11.8. Country-Level Analysis & Forecast

        11.8.1. USA Market Analysis

            11.8.1.1. Introduction

            11.8.1.2. Market Analysis and Forecast by Market Taxonomy

                11.8.1.2.1. By Form

                11.8.1.2.2. By Distribution Channel

        11.8.2. Canada Market Analysis

            11.8.2.1. Introduction

            11.8.2.2. Market Analysis and Forecast by Market Taxonomy

                11.8.2.2.1. By Form

                11.8.2.2.2. By Distribution Channel

12. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        12.3.1. By Country

            12.3.1.1. Mexico

            12.3.1.2. Brazil

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Form

        12.3.3. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Form

        12.4.3. By Distribution Channel

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country-Level Analysis & Forecast

        12.8.1. Mexico Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Form

                12.8.1.2.2. By Distribution Channel

        12.8.2. Brazil Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Form

                12.8.2.2.2. By Distribution Channel

        12.8.3. Argentina Market Analysis

            12.8.3.1. Introduction

            12.8.3.2. Market Analysis and Forecast by Market Taxonomy

                12.8.3.2.1. By Form

                12.8.3.2.2. By Distribution Channel

13. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. United Kingdom

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. Rest of Europe

        13.3.2. By Form

        13.3.3. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Form

        13.4.3. By Distribution Channel

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country-Level Analysis & Forecast

        13.8.1. Germany Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Form

                13.8.1.2.2. By Distribution Channel

        13.8.2. Italy Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Form

                13.8.2.2.2. By Distribution Channel

        13.8.3. France Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Form

                13.8.3.2.2. By Distribution Channel

        13.8.4. UK Market Analysis

            13.8.4.1. Introduction

            13.8.4.2. Market Analysis and Forecast by Market Taxonomy

                13.8.4.2.1. By Form

                13.8.4.2.2. By Distribution Channel

        13.8.5. Spain Market Analysis

            13.8.5.1. Introduction

            13.8.5.2. Market Analysis and Forecast by Market Taxonomy

                13.8.5.2.1. By Form

                13.8.5.2.2. By Distribution Channel

        13.8.6. BENELUX Market Analysis

            13.8.6.1. Introduction

            13.8.6.2. Market Analysis and Forecast by Market Taxonomy

                13.8.6.2.1. By Form

                13.8.6.2.2. By Distribution Channel

        13.8.7. Russia Market Analysis

            13.8.7.1. Introduction

            13.8.7.2. Market Analysis and Forecast by Market Taxonomy

                13.8.7.2.1. By Form

                13.8.7.2.2. By Distribution Channel

14. East Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

        14.3.2. By Form

        14.3.3. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Form

        14.4.3. By Distribution Channel

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country-Level Analysis & Forecast

        14.8.1. China Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Form

                14.8.1.2.2. By Distribution Channel

        14.8.2. Japan Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Form

                14.8.2.2.2. By Distribution Channel

        14.8.3. South Korea Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Form

                14.8.3.2.2. By Distribution Channel

15. South Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Malaysia

            15.3.1.4. Thailand

            15.3.1.5. Rest of South Asia

        15.3.2. By Form

        15.3.3. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Form

        15.4.3. By Distribution Channel

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country-Level Analysis & Forecast

        15.8.1. India Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Form

                15.8.1.2.2. By Distribution Channel

        15.8.2. Indonesia Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Form

                15.8.2.2.2. By Distribution Channel

        15.8.3. Malaysia Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Form

                15.8.3.2.2. By Distribution Channel

        15.8.4. Thailand Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Form

                15.8.4.2.2. By Distribution Channel

16. Oceania Market 2015 to 2021 and Forecast 2022 to 2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Form

        16.3.3. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Form

        16.4.3. By Distribution Channel

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country-Level Analysis & Forecast

        16.8.1. Australia Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Form

                16.8.1.2.2. By Distribution Channel

        16.8.2. New Zealand Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Form

                16.8.2.2.2. By Distribution Channel

17. Middle East and Africa (MEA) Market Analysis 2015 to 2021 and Forecast 2022 to 2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2015 to 2021

    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2022 to 2032

        17.3.1. By Country

            17.3.1.1. GCC Countries

            17.3.1.2. Turkey

            17.3.1.3. South Africa

            17.3.1.4. North Africa

            17.3.1.5. Rest of Middle East and Africa

        17.3.2. By Form

        17.3.3. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Form

        17.4.3. By Distribution Channel

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country-Level Analysis & Forecast

        17.8.1. GCC Countries Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Form

                17.8.1.2.2. By Distribution Channel

        17.8.2. Turkey Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Form

                17.8.2.2.2. By Distribution Channel

        17.8.3. South Africa Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Form

                17.8.3.2.2. By Distribution Channel

        17.8.4. North Africa Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Form

                17.8.4.2.2. By Distribution Channel

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Share Analysis of Top Players

    18.3. Market Concentration

    18.4. Market Presence Analysis

        18.4.1. Regional Footprint Analysis

        18.4.2. Form Footprint Analysis

        18.4.3. Channel Footprint Analysis

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Lonza Group AG

            19.3.1.1. Overview

            19.3.1.2. Form Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Key Developments

            19.3.1.5. Key Financials

            19.3.1.6. SWOT Analysis

            19.3.1.7. Strategy Overview

                19.3.1.7.1. Marketing Strategies

                19.3.1.7.2. Form Strategies

                19.3.1.7.3. Channel Strategies

        19.3.2. Koninklijke DSM N.V.

            19.3.2.1. Overview

            19.3.2.2. Form Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Key Developments

            19.3.2.5. Key Financials

            19.3.2.6. SWOT Analysis

            19.3.2.7. Strategy Overview

                19.3.2.7.1. Marketing Strategies

                19.3.2.7.2. Form Strategies

                19.3.2.7.3. Channel Strategies

        19.3.3. Bactolac Pharmaceutical Inc.

            19.3.3.1. Overview

            19.3.3.2. Form Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Key Developments

            19.3.3.5. Key Financials

            19.3.3.6. SWOT Analysis

            19.3.3.7. Strategy Overview

                19.3.3.7.1. Marketing Strategies

                19.3.3.7.2. Form Strategies

                19.3.3.7.3. Channel Strategies

        19.3.4. Merck KGaA

            19.3.4.1. Overview

            19.3.4.2. Form Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Key Developments

            19.3.4.5. Key Financials

            19.3.4.6. SWOT Analysis

            19.3.4.7. Strategy Overview

                19.3.4.7.1. Marketing Strategies

                19.3.4.7.2. Form Strategies

                19.3.4.7.3. Channel Strategies

        19.3.5. BASF SE

            19.3.5.1. Overview

            19.3.5.2. Form Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Key Developments

            19.3.5.5. Key Financials

            19.3.5.6. SWOT Analysis

            19.3.5.7. Strategy Overview

                19.3.5.7.1. Marketing Strategies

                19.3.5.7.2. Form Strategies

                19.3.5.7.3. Channel Strategies

        19.3.6. Foodchem International Corporation

            19.3.6.1. Overview

            19.3.6.2. Form Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Key Developments

            19.3.6.5. Key Financials

            19.3.6.6. SWOT Analysis

            19.3.6.7. Strategy Overview

                19.3.6.7.1. Marketing Strategies

                19.3.6.7.2. Form Strategies

                19.3.6.7.3. Channel Strategies

        19.3.7. Evonik Industries AG

            19.3.7.1. Overview

            19.3.7.2. Form Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Key Developments

            19.3.7.5. Key Financials

            19.3.7.6. SWOT Analysis

            19.3.7.7. Strategy Overview

                19.3.7.7.1. Marketing Strategies

                19.3.7.7.2. Form Strategies

                19.3.7.7.3. Channel Strategies

        19.3.8. Jubilant Life Sciences Limited

            19.3.8.1. Overview

            19.3.8.2. Form Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Key Developments

            19.3.8.5. Key Financials

            19.3.8.6. SWOT Analysis

            19.3.8.7. Strategy Overview

                19.3.8.7.1. Marketing Strategies

                19.3.8.7.2. Form Strategies

                19.3.8.7.3. Channel Strategies

        19.3.9. Vertellus Specialties Inc.

            19.3.9.1. Overview

            19.3.9.2. Form Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Key Developments

            19.3.9.5. Key Financials

            19.3.9.6. SWOT Analysis

            19.3.9.7. Strategy Overview

                19.3.9.7.1. Marketing Strategies

                19.3.9.7.2. Form Strategies

                19.3.9.7.3. Channel Strategies

        19.3.10. Fagron NV

            19.3.10.1. Overview

            19.3.10.2. Form Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Key Developments

            19.3.10.5. Key Financials

            19.3.10.6. SWOT Analysis

            19.3.10.7. Strategy Overview

                19.3.10.7.1. Marketing Strategies

                19.3.10.7.2. Form Strategies

                19.3.10.7.3. Channel Strategies

        19.3.11. Others

            19.3.11.1. Overview

            19.3.11.2. Form Portfolio

            19.3.11.3. Sales Footprint

            19.3.11.4. Key Developments

            19.3.11.5. Key Financials

            19.3.11.6. SWOT Analysis

            19.3.11.7. Strategy Overview

                19.3.11.7.1. Marketing Strategies

                19.3.11.7.2. Form Strategies

                19.3.11.7.3. Channel Strategies

20. Assumptions and Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Cosmetic Surgery Products Market

Published : August 2023

Healthcare

Skin Replacement Market

Published : June 2022

Explore Healthcare Insights

View Reports

Niacin and Niacinamide Market